These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Similarities and Differences in Neuroimaging. Sun YK; Sun Y; Lin X; Lu L; Shi J Adv Exp Med Biol; 2017; 1010():73-89. PubMed ID: 29098669 [TBL] [Abstract][Full Text] [Related]
5. Animal models for addiction medicine: From vulnerable phenotypes to addicted individuals. Nader MA Prog Brain Res; 2016; 224():3-24. PubMed ID: 26822351 [TBL] [Abstract][Full Text] [Related]
6. PET imaging studies in drug abuse. Fowler JS; Volkow ND J Toxicol Clin Toxicol; 1998; 36(3):163-74. PubMed ID: 9656971 [TBL] [Abstract][Full Text] [Related]
7. Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction. Howell LL; Murnane KS Ann N Y Acad Sci; 2008 Oct; 1141():176-94. PubMed ID: 18991958 [TBL] [Abstract][Full Text] [Related]
8. PET imaging in clinical drug abuse research. Gatley SJ; Volkow ND; Wang GJ; Fowler JS; Logan J; Ding YS; Gerasimov M Curr Pharm Des; 2005; 11(25):3203-19. PubMed ID: 16250850 [TBL] [Abstract][Full Text] [Related]
9. PET imaging for addiction medicine: From neural mechanisms to clinical considerations. Wiers CE; Cabrera E; Skarda E; Volkow ND; Wang GJ Prog Brain Res; 2016; 224():175-201. PubMed ID: 26822359 [TBL] [Abstract][Full Text] [Related]
10. Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET. Buchert R; Obrocki J; Thomasius R; Väterlein O; Petersen K; Jenicke L; Bohuslavizki KH; Clausen M Nucl Med Commun; 2001 Aug; 22(8):889-97. PubMed ID: 11473208 [TBL] [Abstract][Full Text] [Related]
12. Neuroimaging and mechanisms of drug abuse: interface of molecular imaging and molecular genetics. Ernst M; Kimes AS; Jazbec S Neuroimaging Clin N Am; 2003 Nov; 13(4):833-49. PubMed ID: 15024965 [TBL] [Abstract][Full Text] [Related]
13. Toward biomarkers of the addicted human brain: Using neuroimaging to predict relapse and sustained abstinence in substance use disorder. Moeller SJ; Paulus MP Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):143-154. PubMed ID: 28322982 [TBL] [Abstract][Full Text] [Related]
14. Imaging neurotransmitter release by drugs of abuse. Martinez D; Narendran R Curr Top Behav Neurosci; 2010; 3():219-45. PubMed ID: 21161755 [TBL] [Abstract][Full Text] [Related]
15. Food addiction: A common neurobiological mechanism with drug abuse. Lindgren E; Gray K; Miller G; Tyler R; Wiers CE; Volkow ND; Wang GJ Front Biosci (Landmark Ed); 2018 Jan; 23(5):811-836. PubMed ID: 28930574 [TBL] [Abstract][Full Text] [Related]
16. Modelling human drug abuse and addiction with dedicated small animal positron emission tomography. Dalley JW; Fryer TD; Aigbirhio FI; Brichard L; Richards HK; Hong YT; Baron JC; Everitt BJ; Robbins TW Neuropharmacology; 2009; 56 Suppl 1():9-17. PubMed ID: 18614184 [TBL] [Abstract][Full Text] [Related]